248 related articles for article (PubMed ID: 24527719)
1. National Surveillance of Central Diabetes Insipidus (CDI) in Denmark: results from 5 years registration of 9309 prescriptions of desmopressin to 1285 CDI patients.
Juul KV; Schroeder M; Rittig S; Nørgaard JP
J Clin Endocrinol Metab; 2014 Jun; 99(6):2181-7. PubMed ID: 24527719
[TBL] [Abstract][Full Text] [Related]
2. Comparison of incidence of hyponatremia between intranasal and oral desmopressin in patients with central diabetes insipidus.
Kataoka Y; Nishida S; Hirakawa A; Oiso Y; Arima H
Endocr J; 2015; 62(2):195-200. PubMed ID: 25382102
[TBL] [Abstract][Full Text] [Related]
3. Desmopressin as an adjuvant to opioids or NSAIDs in treatment of renal colic: a nationwide register-based study.
Juul KV; Schroeder MK; Rittig S; Nørgaard JP
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1155-60. PubMed ID: 26349846
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study.
Arima H; Oiso Y; Juul KV; Nørgaard JP
Endocr J; 2013; 60(9):1085-94. PubMed ID: 23811987
[TBL] [Abstract][Full Text] [Related]
5. Desmopressin orally disintegrating tablet in Japanese patients with central diabetes insipidus: a retrospective study of switching from intranasal desmopressin.
Murakami T; Hatoko T; Nambu T; Matsuda Y; Matsuo K; Yonemitsu S; Muro S; Oki S
Endocr J; 2014; 61(8):773-9. PubMed ID: 24849384
[TBL] [Abstract][Full Text] [Related]
6. Management of central diabetes insipidus with oral desmopressin lyophilisate in infants.
Korkmaz HA; Demir K; Kılıç FK; Terek D; Arslanoğlu S; Dizdarer C; Ozkan B
J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):923-7. PubMed ID: 24854529
[TBL] [Abstract][Full Text] [Related]
7. Variability in Oral Desmopressin Dose Requirements in Children with Central Diabetes Insipidus.
Almutlaq N; Eugster EA
J Pediatr; 2021 Dec; 239():228-230. PubMed ID: 34487771
[TBL] [Abstract][Full Text] [Related]
8. A Danish population-based cohort study of desmopressin use in adults with nocturia or nocturnal enuresis.
Juul KV; Schrøder MK; Mahler B; Rittig S; Nørgaard JP
Low Urin Tract Symptoms; 2019 Apr; 11(2):O121-O126. PubMed ID: 29992760
[TBL] [Abstract][Full Text] [Related]
9. [Treatment with sublingual desmopressin in two infants with hydranencephaly and central diabetes insipidus].
Marín GR; Baspineiro B; Vilca I
Arch Argent Pediatr; 2018 Feb; 116(1):e93-e97. PubMed ID: 29333830
[TBL] [Abstract][Full Text] [Related]
10. Management of central diabetes insipidus with oral desmopressin in a patient with ectrodactyly and cleft lip/palate (ECP) syndrome.
Ozaydin E; Aycan Z; Yusufoğlu AM; Cetinkaya E; Ergen S; Unal S; Köse G
Turk J Pediatr; 2009; 51(1):89-93. PubMed ID: 19378901
[TBL] [Abstract][Full Text] [Related]
11. Desmopressin use in pediatric nocturnal enuresis patients: is there a sex difference in prescription patterns?
Schroeder MK; Juul KV; Mahler B; Nørgaard JP; Rittig S
Eur J Pediatr; 2018 Mar; 177(3):389-394. PubMed ID: 29260376
[TBL] [Abstract][Full Text] [Related]
12. Vasopressin and desmopressin in central diabetes insipidus: adverse effects and clinical considerations.
Kim RJ; Malattia C; Allen M; Moshang T; Maghnie M
Pediatr Endocrinol Rev; 2004 Nov; 2 Suppl 1():115-23. PubMed ID: 16456490
[TBL] [Abstract][Full Text] [Related]
13. Desmopressin administration in children with central diabetes insipidus: a retrospective review.
Ooi HL; Maguire AM; Ambler GR
J Pediatr Endocrinol Metab; 2013; 26(11-12):1047-52. PubMed ID: 23843580
[TBL] [Abstract][Full Text] [Related]
14. The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis.
Robson WL; Leung AK; Norgaard JP
J Urol; 2007 Jul; 178(1):24-30. PubMed ID: 17574054
[TBL] [Abstract][Full Text] [Related]
15. Buccally Administered Intranasal Desmopressin Acetate for the Treatment of Neurogenic Diabetes Insipidus in Infancy.
Smego AR; Backeljauw P; Gutmark-Little I
J Clin Endocrinol Metab; 2016 May; 101(5):2084-8. PubMed ID: 27011115
[TBL] [Abstract][Full Text] [Related]
16. Severe hyponatremia due to desmopressin.
Kelleher HB; Henderson SO
J Emerg Med; 2006 Jan; 30(1):45-7. PubMed ID: 16434334
[TBL] [Abstract][Full Text] [Related]
17. Comments on "Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study"--efficacy and safety of orally disintegrating desmopressin tablets in patients with central diabetes insipidus.
Kamoi K
Endocr J; 2013; 60(9):1115. PubMed ID: 23863202
[No Abstract] [Full Text] [Related]
18. Management of diabetes insipidus and adipsia in the child.
Di Iorgi N; Morana G; Napoli F; Allegri AE; Rossi A; Maghnie M
Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):415-36. PubMed ID: 26051300
[TBL] [Abstract][Full Text] [Related]
19. Desmopressin duration of antidiuretic action in patients with central diabetes insipidus.
Juul KV; Bichet DG; Nørgaard JP
Endocrine; 2011 Aug; 40(1):67-74. PubMed ID: 21626284
[TBL] [Abstract][Full Text] [Related]
20. Treatment of neurogenic diabetes insipidus.
Chanson P; Salenave S
Ann Endocrinol (Paris); 2011 Dec; 72(6):496-9. PubMed ID: 22071315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]